merck moderna - Search News

Moderna cancer vaccine stops melanoma returning

Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma

Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients...

· 1d · on MSN

Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

· 9h

Moderna, Merck See Promise in Experimental Skin Cancer Vaccine

· 11h

From Covid to Cancer: How Moderna’s Stock Jumped 177% in a Day

On Wednesday, those efforts began to pay off in a big way.

· 21h

Potential new skin cancer vaccine

· 1d

Moderna and Merck Say mRNA Vaccine Prevents Melanoma From Returning

· 1d

Skin cancer breakthrough after experimental mRNA drug found to prevent disease returning

The vaccine, called intismeran, which is personalized for each patient, succeeded in preventing melanoma from coming back or spreading in people who had surgery to remove the cancer when combined with...

· 1d

Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success

· 1d

Moderna surges as Merck-partnered melanoma vaccine cuts recurrence in large trial

BioSpace

Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future

Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so the Phase 3 win was a welcome surprise.

19h

Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades

Merck (MRK) stock slips as RBC Capital Markets cuts on valuation while Morgan Stanley upgrades on trial data for Moderna (MRNA)-partnered cancer shot. Read more here.

Moderna, Merck, SK Hynix, Micron, Target, Estée Lauder, and More Stocks That Explain Today’s Market

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.